HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 870738Generated: October 31, 2026
Nitrogen → 1-(4-(3-(3-Methoxypyridin-4-yl)imidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl)-3,3-dimethylbutan-1-one di-hydrochloride salt
https://huagongshe.com/reaction/870738
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Nitrogen | HCID 947 | — |
| Reactant | Dichloromethane | HCID 6344 | — |
| Reactant | Potassium phosphate, tribasic, monohydrate | HCID 22031701 | — |
| Reactant | 3-Methoxypyridine-4-boronic acid hydrate | HCID 46739018 | — |
| Reactant | 1-(4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl)-3,3-dimethylbutan-1-one | HCID 86696446 | — |
| Catalyst | Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+) | HCID 178418228 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | 1,2-Dimethoxyethane | HCID 8071 | — |
| Product | 1-(4-(3-(3-Methoxypyridin-4-yl)imidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl)-3,3-dimethylbutan-1-one di-hydrochloride salt | HCID 89802633 | 248% |
Reaction Steps
To a mixture of 1-(4-(3-bromoimidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl)-3,3-dimethylbutan-1-one (168.9 mg, 0.4 mmol), 3-methoxypyridine-4-boronic acid hydrate [1072952-50-1] (82.3 mg, 0.5 mmol), potassium phosphate tribasic monohydrate [27176-10-9] (210.4 mg, 0.9 mmol), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II), complex with dichloromethane [95464-05-4] (33.8 mg, 0.1 mmol) contained in a 25 mL round bottomed flask was added a solution of 30% (v/v) water in 1,2-dimethoxyethane (13 mL) and a magnetic stir bar. The reaction pot was fitted to a reflux condenser, lowered into an ambient temperature oil bath, and the system taken through 10 evacuation/N2 blanket cycles while being rapidly stirred. The rapidly stirred, N2 blanketed, reaction was heated to an oil bath temperature of 85° C. for 17 h then cooled and partitioned between brine (pH adjusted to 10 with 3N aqueous sodium hydroxide) and ethyl acetate. The phase separated extract was dried (MgSO4) and evaporated to afford a brown oil which was purified by preparative RP-HPLC. Isolated product was dissolved in methanol, diluted with concentrated hydrochloric acid, evaporated to dryness, redissolved in methanol and precipitated by the addition of diethyl ether. Filtration of the precipitate yielded 59.7 mg of 1-(4-(3-(3-methoxypyridin-4-yl)imidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl)-3,3-dimethylbutan-1-one di-hydrochloride salt as a light yellow powder, mp. 211-212° C. (dec). 1H NMR (400 MHz, DMSO-d6) δ ppm 1.00-1.04 (m, 9H) 2.26-2.35 (m, 2H) 3.57-3.66 (m, 4H) 3.70 (br. s., 4H) 4.14-4.21 (m, 3H) 7.68 (d, J=9.85 Hz, 1H) 8.20 (dd, J=10.10, 2.02 Hz, 1H) 8.65 (d, J=2.53 Hz, 2H) 8.75-8.80 (m, 1H) 9.04-9.10 (m, 1H). 13C NMR (100 MHz, DMSO-d6) δ ppm 29.70, 30.94, 43.69, 45.00, 45.43, 45.70, 57.70, 115.22, 119.35, 121.79, 124.70, 126.64, 130.45, 134.42, 135.21, 136.68, 152.58, 155.32, 169.63. LRMS (ESI) m/z 409.2 [(M+H)]+, calc'd for C22H28N6O2: 408.50.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08969565B2 |
|---|
| Source dataset | uspto-grants-2015_03 |
|---|
| ORD ID | ord-7109439ca2e541229263748f82e399eb |
|---|
| Source note | uspto-grants-2015_03 |
|---|